Lepu Biotechnology’s MRG003 Gains Fast-Track Status from U.S. FDA for Nasopharyngeal Carcinoma
Lepu Biotechnology Co., Ltd (HKG: 2157), based in China, has announced that its flagship product...
Nona Biosciences Partners with Lycia Therapeutics to Advance LYTAC Platform for Novel Therapies
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has announced a collaboration...
Concentra Biosciences Targets China-Based Biotech LianBio in Unsolicited Takeover Bid
LianBio (OTCMKTS: LIANY), a China-based biotech firm, has become the target of an unsolicited takeover...
FDA Investigates Safety of China-Made Plastic Syringes Due to Quality Concerns
The US Food and Drug Administration (FDA) has issued a warning that it is investigating...
China’s State Council Unveils Comprehensive Plan to Boost Beijing’s Healthcare Sector
The State Council has unveiled a comprehensive “Work Plan” aimed at enhancing Beijing’s service industry...
Bayer Partners with CrossBay Medical to Enhance Hormonal IUS Delivery System
Germany’s Bayer (ETR: BAYN) has announced a strategic partnership with women’s health innovator CrossBay Medical...
Johnson & Johnson Acquires Laminar for $400 Million to Enhance Heart Rhythm Solutions
Johnson & Johnson (J&J; NYSE: JNJ) has finalized the acquisition of medical device manufacturer Laminar...
MSD to Migrate IT Systems to AWS, Aiming for Faster Drug Discovery and Clinical Trials
Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced plans to transition a significant portion...
Akeso’s AK111 Achieves Key Efficacy Milestones in Phase III Trial for Plaque Psoriasis
Akeso Biopharma (HKG: 9926), based in China, has announced that its pivotal Phase III clinical...
Sichuan Kelun-Biotech to Present Promising Phase II Results for SKB264 in mTNBC at SABCS 2023
Sichuan Kelun Pharmaceutical Co., Ltd’s (SHE: 002422) innovative drug development subsidiary, Sichuan Kelun-Biotech Biopharmaceutical Co.,...
TG ImmunoPharma Secures U.S. FDA IND Approval for Promising mAb TGI-5 Targeting Multiple Cancers
TG ImmunoPharma Co., Ltd, based in China, has announced that it has received Investigational New...
Insilico Medicine Launches Clinical Study for First-in-Class PHD Inhibitor ISM5411 in IBD
Insilico Medicine, a China-based biotech leveraging generative artificial intelligence (AI), has announced the initiation of...
Simcere Secures NMPA Approval for Edaravone Sublingual Tablets Targeting Post-Stroke Cognitive Impairment
Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has received clinical trial approval from the National...
Everest Medicines Reports Positive Phase III Results for Velsipity in Ulcerative Colitis
Everest Medicines (HKG: 1952), based in China, has announced positive topline results from a multi-center...
Acotec Secures FDA IDE Approval for AcoArt Litos Paclitaxel-Coated Balloon Catheter
Acotec Scientific Holdings Ltd (HKG: 6669), based in China, has received Investigational Device Exemption (IDE)...
Perpetual Medicines Launches with $8 Million Seed Round, Led by Chengwei Capital
Perpetual Medicines, a biotech firm with operations in Shanghai and Boston, has officially launched, announcing...
Takeda Reinforces Takeda Spark Incubator Program with Expanded Partnerships in China
Takeda (TYO: 4502) has reportedly renewed and expanded a series of partnerships to bolster its...
Novocure Restructures and Prioritizes Pipeline Amid Anticipated NSCLC Approval
Novocure (NASDAQ: NVCR), a Switzerland-based developer of Tumor Treating Fields (TTFields) cancer therapeutic technology that...
AbbVie’s Telisotuzumab-Vedotin Shows Promising Results in NSCLC Phase 2 Trial
AbbVie (NYSE: ABBV) has unveiled data from a Phase 2 trial of its potential first-in-class...